Agenda
AgendaParticipant ListFinal Report
Workshop Objectives
The workshop aims to highlight the importance of advancing HIV cure research, discuss critical clinical research issues and solutions, and explore collaborative strategies to accelerate progress in cure research. Different approaches to HIV cure will be considered in this workshop, with a focus on approaches utilizing broadly neutralizing antibodies.
Session I: Welcome, Workshop Overview
Welcome, Housekeeping, Workshop Overview
Ekene Osakwe, Forum for Collaborative Research
Introductory Remarks, Meeting Goals and Scope
Veronica Miller, Forum for Collaborative Research
Session II: Where We Are with HIV Cure
HIV in 2025: Treatment and Research Towards Cure or Control
David Margolis, The University of North Carolina at Chapel Hill
Current HIV Cure Research Landscape and Challenges
Richard Jefferys, Treatment Action Group*
Lessons Learned from HIV Cure Research, Most Promising Strategies, and Key Challenges
Katherine Bar, University of Pennsylvania
Panel/Open Discussion
All Speakers +
Jo Josh, British HIV Association*
Karl Salzwedel, National Institute of Allergy and Infectious Disease
Moses Supercharger, Joint Adherent Brothers and Sisters Against AIDS
Session III: Specific HIV Cure Research Programs
ENTRANCE: ViiV’s 1st Cure and Remission Study
Peter Leone, ViiV Healthcare*
Gilead’s Strategy: Driving Innovation to Cure
Jeff Murry, Gilead Sciences
Towards a Scalable and Transformative Cure for HIV
Steven Deeks, University of California, San Francisco
Strategies to Reduce and Control the HIV Reservoir
Sharon Lewin, University of Melbourne*
Panel/Open Discussion
All Speakers +
Boris Juelg, Ragon Institute
Sharana Mahomed, CAPRISA*
Javier Martinez-Picado, IrsiCaixa*
Martha Sichone-Cameron, International Community of Women Living with HIV
Session IV: Challenges, Strategies, and Ethical Considerations for HIV Cure Clinical Trials Research
Clinical Trial Design Challenges and Potential Solutions
Marina Caskey, Rockefeller University
Trial Design Considerations for Pediatric Populations
Dwight Yin, National Institute of Allergy and Infectious Disease
Analytical Treatment Interruptions, Challenges, and Recommendations
Catherine Koofhethile, Botswana Harvard Health Partnership
Panel/Open Discussion
All Speakers +
Kedibone Malatji, South African Health Products Regulatory Authority*
Deborah Persaud, Johns Hopkins University
Jon Heinrichs, International AIDS Vaccine Initiative
Jeremy Sugarman, Johns Hopkins University
Lynda Dee, AIDS Action Baltimore
Session V: Collaborative Approaches and Funding for HIV Cure Research
Panel/Open Discussion
Mike McCune, Gates Foundation*
Casper Rokx, EU2Cure*
Victoria Kasprowicz, SANTHE Africa*
Monique Nijhuis, SPIRAL
Albert Machinda, African HIV Cure Consortium*
Allan Tenorio, ViiV Healthcare
Elena Vendrame, Gilead Sciences
Rafael Campo, Merck
Jessica Salzwedel, AVAC
Session VI: Meeting Closing and Summary
Call to Action, Next Steps, Concluding Remarks
Robin Schaefer, Forum for Collaborative Research*
Veronica Miller, Forum for Collaborative Research
* Remote Participation